Skip to main content
×
×
Home

The use of ginkgo biloba in the treatment of dementia

  • Ian Maidment (a1)
Abstract
Aims and Method

To assess and update the available data on use of ginkgo to treat dementia. A Medline search as conducted for the period January 1985 to October 2000. The search included other aspects of the usage of ginkgo, such as side-effects, mechanism of action and drug interactions.

Results

Most of the trials using ginkgo were to treat cerebral insufficiency. Only five trials could be identified that used ginkgo to treat dementia. There are no trials comparing ginkgo to cholinesterase inhibitors such as donepezil.

Clinical Implications

Ginkgo is generally well-tolerated and appears to ease the symptoms of dementia. Although it has been suggested that the effect is comparable to donepezil, confirmation from controlled studies is required.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The use of ginkgo biloba in the treatment of dementia
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The use of ginkgo biloba in the treatment of dementia
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The use of ginkgo biloba in the treatment of dementia
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. (3rd edn)(DSM–III–R). Washington, DC: APA.
Collegium Internationale Psychiatriae Scalarum (eds) (1986) Internationale Skalen für Psychiatrie (3rd edn). Weinheim: Beltz-Test GmbH.
Erzigkeit, H. (1986) Der Syndrom-Kurztest zur Erfassung von Aufmerksamkeits-und Gedachtnisstorungen (The Syndrome Short-test for the Assessment of Disturbed Concentration and Memory). Vaterstetten (F. R. G.): Vless-Verlagsgesellschaft.
Fugh-Berman, A. (2000) Herb–drug interactions. Lancet, 355, 134138.
Fugh-Berman, A. & Cott, J. M. (1999) Dietary supplements and natural products as psychotherapeutic agents. Psychosomatic Medicine, 61, 712728.
Gaby, A. R. (1996) Ginkgo biloba extract: a review. Alternative Medicine Review, 1, 236242.
Guy, W. (ed.) (1970) ECDEU Assessment Manual for Psychopharmacology. Publication ADM 76–338, pp 190194. Rockville, MD: US Department of Health Education and Welfare.
Guy, W. (ed.) (1976) ECDEU Assessment Manual for Psychopharmacology. Publication ADM 76–338, pp. 218222. Rockville, MD: US Department of Health Education and Welfare.
Hofferberth, B. (1994) The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type: a double-blind, placebo-controlled study on different levels of investigation. Human Psychopharmacology, 9, 215222.
Kanowski, S., Herrmann, W. M., Stephen, K., et al (1997) Proof of efficacy of the ginkgo biloba extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Phytomedicine, 4, 313.
Kleijnen, J. & Knipschild, P. (1992a) Ginkgo biloba. Lancet, 340, 11361139.
Kleijnen, J. & Knipschild, P. (1992b) Ginkgo biloba for cerebral insufficiency. British Journal of Clinical Pharmacology, 34, 353358.
Le Bars, P. L., Katz, M. M., Berman, N., et al (1997) A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. Journal of the American Medical Association, 278, 13271332.
Maurer, K., Ihl, R., Dierks, T., et al (1997) Clinical efficacy of ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. Journal of Psychiatric Research, 31, 645655.
Oken, B. S., Storbach, D. M. & Kaye, J. A. (1998) The efficacy of ginkgo biloba on cognitive function in Alzheimer's disease. Archives of Neurology, 55, 14091415.
Oswald, W. D. & Fleischmann, U. M. (1986) Nurnberger-Alters-Inventar (NAI: Nuremberg Age Inventory). Universitat Erlangen-Nurnberg: Psychologisches Institut II.
Robinson, R. A. (1964) The diagnosis and prognosis of dementia. In Current Achievements in Geriatrics (ed. Anderson, W. E.), pp. 190203. London: Cassell.
Rogers, S. L., Farlow, M. R., Doody, R. S., et al (1998) A 24-week double-blind placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology, 7, 293303.
Rosen, W. G., Mohs, R. C. & Davis, K. L. (1984) A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 13561364.
Schwartz, G. E. (1983) Development and Validation of the Geriatric Evaluation by Relative's Rating Instrument (GERRI). Psychological Reports, 53, 479480.
Shader, R. I., Harmatz, J. S. & Salzmann, C. (1974) A new scale for clinical assessment on geriatric population: SANDOZ Clinical Assessment – Geriatric (SCAG). Journal of the American Geriatric Society, 22, 107113.
Van Dongen, M. C. J. M., Van Rossum, E., Kessels, A. G. H., et al (2000) The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomised clinical trial. Journal of the American Geriatric Society, 48, 11831194.
Wesnes, K., Simmons, D., Rook, M., et al (1987) A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly. Human Psychopharmacology, 2, 159169.
Wong, A. H. C., Smith, M. & Boon, H. S. (1998) Herbal remedies in psychiatric practice. Archives of General Psychiatry, 55, 10331044.
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioral Disorders. Geneva: WHO.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 3
Total number of PDF views: 17 *
Loading metrics...

Abstract views

Total abstract views: 213 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 23rd July 2018. This data will be updated every 24 hours.

The use of ginkgo biloba in the treatment of dementia

  • Ian Maidment (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *